With their shares having surged by more than 484%, 500% and 275%, respectively, the three stocks highlighted in today’s article are three of the best-performing pharmaceutical stocks over the past year – and despite them having already experienced monster moves higher, it may not be too late to get in on these stocks’ gains. For more on these three pharmaceutical…
Today’s article highlights two “compelling small-cap stocks that combine a low cost of entry with the Street’s backing.” More specifically, these two stocks – a biotech firm and a pharmaceutical company – are currently trading for less than $8 a share, have earned “Strong Buy” consensus analyst ratings, and boast significant upside potential. For more, CLICK HERE.
The ten stocks identified in today’s article may be nice stocks to trade for short-term profit, but you may not want to bet your retirement portfolio on them. Specifically, the author identifies ten stocks that he argues “are more likely to hurt your retirement than help it” as they lack what he sees as the critical feature for retirement stocks:…